Transcranial photobiomodulation improves prefrontal oxygenation and impulse control in adults with ADHD: a randomized controlled trial.
Farzad Salehpour, Douglas W Barrett, Anagh Mirji...
https://pubmed.ncbi.nlm.nih.gov/42449279/Actively Recruiting
Led by Francisco Gonzalez-Lima, PhD · Updated on 2026-06-22
500
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the effects of transcranial photobiomodulation tPBM, a non-invasive near-infrared light stimulation, on attention in adults with and without attention deficit hyperactivity disorder ADHD. This study aims to determine if tPBM can improve inattention, impulsivity, sustained attention, and vigilance. The investigation is motivated by the hypothesis that reduced brain metabolism in the prefrontal cortex contributes to inattentiveness in ADHD, and that tPBM may activate this brain area. Participants will be randomly assigned to receive either active tPBM using 1064 nm light or a sham inactive treatment applied to the right prefrontal cortex for 8 minutes. The study includes adults both with a medical diagnosis of ADHD and without. After the light treatment, participants complete a 14-minute computer-based attention task called the Conners continuous performance task-3 CPT-3 to assess cognitive effects. Both groups undergo the same procedures except the infrared light is either turned on or off depending on their assigned condition. During the study, participants will be assessed using the CPT-3 and functional near-infrared spectroscopy over a period of up to two months. Researchers will monitor changes in attention, impulsivity, and brain oxygenation to evaluate the impact of tPBM. Participant involvement includes the light stimulation session followed by cognitive testing, with assessments repeated to measure sustained effects. The study is double-blinded and randomized, aiming to provide insight into the neurocognitive effects of near-infrared light on adults attention.
CONDITIONS
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
F
Francisco Gonzalez-Lima, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Francisco Gonzalez-Lima, PhD
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Active tPBM | Sham tPBM | Typical medication and behavioral therapy |
|---|---|---|---|
| What it is | A device-based method using near-infrared light (tPBM) applied to the prefrontal cortex | A sham (placebo) version of the same device treatment without therapeutic light emission | Adults with ADHD are typically treated with stimulant medication plus behavioral therapy |
| Role in trial | Investigational arm receiving active tPBM | Placebo control arm receiving sham tPBM | Represents commonly used current treatments outside trial |
| Primary use | To evaluate whether active tPBM can improve attention and impulse control | Control condition to separate active effects from placebo | To manage ADHD symptoms with established methods |
| How it is given or performed | 1064 nm near‑infrared light applied to prefrontal cortex via device | Same device procedure without light emission | Medication taken orally as prescribed; behavioral therapy in structured sessions |
| Evidence status | One recent randomized trial showed active tPBM improved impulsivity and attention compared to sham | Sham tPBM serves as placebo; no expected active effect | Medications and behavioral therapy have established benefits for attention and impulse control |
| Important limitations | Evidence is limited to a few small studies; long‑term effects and optimal protocols are uncertain | Placebo provides no therapeutic benefit; only useful for control comparison | Some individuals do not tolerate medication or respond fully; access to behavioral therapy may vary |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single session
Participants receive either active transcranial photobiomodulation (tPBM) with near-infrared light or a sham treatment where the device is turned off. After the treatment session, participants complete a computer-based attention task to assess cognitive effects.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Farzad Salehpour, Douglas W Barrett, Anagh Mirji...
https://pubmed.ncbi.nlm.nih.gov/42449279/Francisco Gonzalez-Lima, PhD
Lead Sponsor